EP 1711490 A4 20070404 - NOVEL P-GLYCOPROTEIN INHIBITOR, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
Title (en)
NOVEL P-GLYCOPROTEIN INHIBITOR, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
Title (de)
NEUER P-GLYCOPROTEININHIBITOR, VERFAHREN ZU DESSEN HERSTELLUNG UND PHARMAZEUTISCHE ZUSAMMENSETZUNG, DIE DIESEN ENTHÄLT
Title (fr)
INHIBITEUR DE P-GLYCOPROTEINE, PROCEDE DE PREPARATION, ET COMPOSITION PHARMACEUTIQUE LE RENFERMANT
Publication
Application
Priority
- KR 2004002557 W 20041007
- KR 20030069803 A 20031008
Abstract (en)
[origin: WO2005033101A1] A p-glycoprotein inhibitor of Formula 1 is capable of effectively preventing the development of multi-drug resistance directed to an anticancer agent in cancer cells, and greatly enhances the bioavailability of the drug, such as paclitaxel, which is not readily absorbed when orally administered.
IPC 8 full level
C07D 405/12 (2006.01)
CPC (source: EP KR)
C07D 405/12 (2013.01 - EP KR)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 2005033101A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005033101 A1 20050414; EP 1711490 A1 20061018; EP 1711490 A4 20070404; KR 100580743 B1 20060515; KR 20050034024 A 20050414
DOCDB simple family (application)
KR 2004002557 W 20041007; EP 04774781 A 20041007; KR 20030069803 A 20031008